Autoantibodies against chemokines linked with better disease outcomes in COVID-19.
作者信息
Bordon Yvonne
机构信息
Nature Reviews Immunology, .
出版信息
Nat Rev Immunol. 2023 Apr;23(4):203. doi: 10.1038/s41577-023-00860-2.
Abstract
摘要
相似文献
1
Autoantibodies against chemokines linked with better disease outcomes in COVID-19.针对趋化因子的自身抗体与COVID-19更好的疾病转归相关。
Nat Rev Immunol. 2023 Apr;23(4):203. doi: 10.1038/s41577-023-00860-2.
2
The kinetics of chemokine autoantibodies in COVID-19.新型冠状病毒肺炎中趋化因子自身抗体的动力学
Nat Immunol. 2023 Apr;24(4):567-569. doi: 10.1038/s41590-023-01455-8.
3
Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19.社论：针对免疫系统成分（包括 1 型干扰素）的自身抗体与 COVID-19 重症风险。
Med Sci Monit. 2021 Sep 20;27:e934766. doi: 10.12659/MSM.934766.
4
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.横断面分析揭示了与新冠病毒疾病严重程度相关的自身抗体特征。
J Med Virol. 2023 Feb;95(2):e28538. doi: 10.1002/jmv.28538.
5
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.危重症 COVID-19 患者若存在针对 I 型干扰素的中和自身抗体，其疱疹病毒病风险增加。
PLoS Biol. 2022 Jul 5;20(7):e3001709. doi: 10.1371/journal.pbio.3001709. eCollection 2022 Jul.
6
Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.重症 COVID-19 患者的自身抗体并未针对常见诊断自身抗原而升高。
Clin Chem Lab Med. 2022 Apr 28;60(7):1116-1123. doi: 10.1515/cclm-2022-0239. Print 2022 Jun 27.
7
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.严重 COVID-19 患者的免疫球蛋白 A 自身抗体可抑制肺表面活性剂蛋白。
Am J Respir Crit Care Med. 2023 Jan 1;207(1):38-49. doi: 10.1164/rccm.202201-0011OC.
8
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.抗血管紧张素转换酶 2（ACE2）和血管紧张素 I 型受体自身抗体增加 COVID-19 严重程度。
J Autoimmun. 2021 Aug;122:102683. doi: 10.1016/j.jaut.2021.102683. Epub 2021 Jun 11.
9
The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity.在 COVID-19 患者中可检测到的抗干扰素-γ自身抗体可能与疾病严重程度有关。
Virol J. 2023 Feb 21;20(1):33. doi: 10.1186/s12985-023-01989-1.
10
Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients.COVID-19 患者重症监护病房中 I 型干扰素和人类内源性逆转录病毒 W 抗体的存在增加。
Microbiol Spectr. 2022 Aug 31;10(4):e0128022. doi: 10.1128/spectrum.01280-22. Epub 2022 Jul 19.
引用本文的文献
1
Comprehensive bioinformatics analysis and systems biology approaches to identify the interplay between COVID-19 and pericarditis.综合生物信息学分析和系统生物学方法鉴定 COVID-19 与心包炎之间的相互作用。
Front Immunol. 2024 Feb 22;15:1264856. doi: 10.3389/fimmu.2024.1264856. eCollection 2024.
本文引用的文献
1
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.感染 SARS-CoV-2 后针对趋化因子的自身抗体与疾病进程相关。
Nat Immunol. 2023 Apr;24(4):604-611. doi: 10.1038/s41590-023-01445-w. Epub 2023 Mar 6.
Zotero 插件